A four to six month launch window. A four to six week MLR cycle. An average of two and a half rounds of rework. That math does not close, and most organizations are still running review models built twenty years ago. Lou Pillai reframes it: MLR was never about citations. It is a governance model for your risk posture. The leverage is upstream in modular content, not in speeding up the review meeting. For a small team commercializing for the first time, that arithmetic is fata

I have pulled together launch dashboards. Most tell you what happened, and by the time the room agrees on why, the window has moved. Lou Pillai calls the fix the orchestration layer, and is blunt that it is not a program management exercise. The capability worth sitting with: AI can surface the heuristics your 30-year super specialist carries in their head, while the decision is still live. One line stays above the dashboard. AI cannot take accountability. Having launched mul

Your best launch plan has a shelf life of about three months. That is how long a single tactic has traditionally taken to turn around, inside a window that runs six months to a year. Lou Pillai on what changes when a launch runs as a closed loop rather than a static map. The stakes show up at patient access, where a two-week wait starts costing you prescribers. That three months is the honest number: rework the content, re-run the review, get it back into the field. Teams can

That gap, between knowing what good looks like and being able to act while the market is still moving, is what I wanted to put to someone who has lived it. Lou has spent three decades in commercialization and has since sat on the other side of the table, advising the teams making these calls. Not a vendor with a platform to sell. An operator who has watched launches drift in real time and can tell you where and why. My thanks to him for a genuinely candid hour, and for being